CSI Market
Sign In | Register

Genmab A (GMAB) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GMAB Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Genmab A manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		0 0 0 (Dec 31 2024)
Operating Activities
Income187.73
Depreciation & amortization8.58
Amortization of Other Assets2.49
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss4.99
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments-0.47
Financial Instruments and Foreign Currency Transaction5.00
Adjustments For Finance Income-
Adjustments For Finance Costs-
Adjustments For Sharebased Payments-
Adjustments For Decrease Increase In Trade And Other Receivables-
Adjustments For Decrease Increase In Inventories-
Adjustments For Increase Decrease In Other Liabilities-
Cash Flow From Used In Operating Activities Before Financial Items-
Adjustments For Interest On Lease Payments-
Adjustments For Income Tax Expense-
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities-
Purchase Of Other Longterm Assets Classified As Investing Activities-
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities2.81
Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities5,712.00
Discontinued operations0.00
Net Cash flow from Operating Activities184.92
Investing Activities
Capital Expenditures5.77
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Purchase Of Investments Other Than Investments Accounted For Using Equity Method154.52
Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans2.81
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-7,237.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-879.86
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net746.71
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities746.71
Effect of exchange rate on cash flow3.00
Discontinued operations1,715.00
Free Cash Flow190.69
Total Cash Flow1,380.00
4 historic quarters locked

Sign in to unlock the full Genmab A cash flow history.

Sign In Create Free Account

About Genmab A s Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001434265-26-000014

Figures are derived from filed reports and may be restated. Historical data is subject to revision.